Your browser doesn't support javascript.
loading
Plasminogen activation triggers transthyretin amyloidogenesis in vitro.
Mangione, P Patrizia; Verona, Guglielmo; Corazza, Alessandra; Marcoux, Julien; Canetti, Diana; Giorgetti, Sofia; Raimondi, Sara; Stoppini, Monica; Esposito, Marilena; Relini, Annalisa; Canale, Claudio; Valli, Maurizia; Marchese, Loredana; Faravelli, Giulia; Obici, Laura; Hawkins, Philip N; Taylor, Graham W; Gillmore, Julian D; Pepys, Mark B; Bellotti, Vittorio.
Affiliation
  • Mangione PP; From the Wolfson Drug Discovery Unit, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London NW3 2PF, United Kingdom.
  • Verona G; Department of Molecular Medicine, Institute of Biochemistry, University of Pavia, 27100 Pavia, Italy.
  • Corazza A; From the Wolfson Drug Discovery Unit, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London NW3 2PF, United Kingdom.
  • Marcoux J; From the Wolfson Drug Discovery Unit, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London NW3 2PF, United Kingdom.
  • Canetti D; Department of Medicine (DAME), University of Udine, 33100 Udine, Italy.
  • Giorgetti S; Istituto Nazionale Biostrutture e Biosistemi, 00136 Roma, Italy.
  • Raimondi S; Institut de Pharmacologie et de Biologie Structurale, Université de Toulouse, CNRS, UPS, 31000 Toulouse, France.
  • Stoppini M; From the Wolfson Drug Discovery Unit, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London NW3 2PF, United Kingdom.
  • Esposito M; Department of Molecular Medicine, Institute of Biochemistry, University of Pavia, 27100 Pavia, Italy.
  • Relini A; Department of Molecular Medicine, Institute of Biochemistry, University of Pavia, 27100 Pavia, Italy.
  • Canale C; Department of Molecular Medicine, Institute of Biochemistry, University of Pavia, 27100 Pavia, Italy.
  • Valli M; From the Wolfson Drug Discovery Unit, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London NW3 2PF, United Kingdom.
  • Marchese L; Department of Chemistry and Industrial Chemistry, University of Genoa, 16146 Genoa, Italy.
  • Faravelli G; Department of Physics, University of Genoa, 16146 Genoa, Italy.
  • Obici L; Department of Molecular Medicine, Institute of Biochemistry, University of Pavia, 27100 Pavia, Italy.
  • Hawkins PN; Department of Molecular Medicine, Institute of Biochemistry, University of Pavia, 27100 Pavia, Italy.
  • Taylor GW; Department of Molecular Medicine, Institute of Biochemistry, University of Pavia, 27100 Pavia, Italy.
  • Gillmore JD; Amyloidosis Research and Treatment Center, Foundation IRCCS Policlinico San Matteo, 27100 Pavia, Italy.
  • Pepys MB; National Amyloidosis Centre, University College London and Royal Free Hospital, London NW3 2PF, United Kingdom.
  • Bellotti V; From the Wolfson Drug Discovery Unit, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London NW3 2PF, United Kingdom.
J Biol Chem ; 293(37): 14192-14199, 2018 09 14.
Article in En | MEDLINE | ID: mdl-30018138
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Plasminogen / Prealbumin / Amyloidosis Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Biol Chem Year: 2018 Type: Article Affiliation country: United kingdom
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Plasminogen / Prealbumin / Amyloidosis Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Biol Chem Year: 2018 Type: Article Affiliation country: United kingdom